Hasman A, McIntosh E, Hope T
Royal Pharmaceutical Societyof Great Britain, London, UK.
J Med Ethics. 2008 Sep;34(9):658-63. doi: 10.1136/jme.2007.023366.
Priority setting is necessary in current healthcare services. Discussion of fair process has highlighted the value of developing reasons for allocation decisions on the basis of experience gained from real cases.
To identify the reasons that those with experience of real decision-making concerning resource allocation think relevant in deciding on the priority of a new but expensive drug treatment.
Semistructured interviews with members of committees with responsibility for making resource allocation decisions at a local level in the British National Health Service, analysed using modified grounded theory.
22 interviews were carried out. 14 reasons were identified. Four reasons were almost universally considered most important: cost effectiveness; clinical effectiveness; equality and gross cost. No one reason was considered dominant. Some considerations, such as political directives and fear of litigation, were thought by many participants to distort decision-making. There was a substantial lack of agreement over the relevance of some reasons, such as the absence of alternative treatment for the condition.
There is a clear consensus on the importance and role of a limited number of reasons in allocation decisions among participants. A focus on the process of decision-making, however, does not obviate the need for those involved in the process to engage with problematical ethical issues, nor for the importance of further ethical analysis.
在当前的医疗服务中,确定优先次序是必要的。对公平程序的讨论凸显了根据实际案例经验为分配决策制定理由的价值。
确定那些有资源分配实际决策经验的人认为在决定一种新的但昂贵的药物治疗的优先次序时相关的理由。
对英国国民医疗服务体系中负责在地方层面做出资源分配决策的委员会成员进行半结构化访谈,并采用改进的扎根理论进行分析。
进行了22次访谈。确定了14个理由。四个理由几乎被普遍认为是最重要的:成本效益;临床疗效;公平性和总成本。没有一个理由被认为是主导性的。许多参与者认为一些因素,如政治指令和对诉讼的担忧,会扭曲决策。对于一些理由的相关性,如该病症没有替代治疗方法,存在很大分歧。
参与者在分配决策中对少数几个理由的重要性和作用达成了明确共识。然而,关注决策过程并不能消除参与该过程的人应对有问题的伦理问题的必要性,也不能消除进一步进行伦理分析的重要性。